Apollo Hospitals Enterprise Ltd.

View in App
4957.90 +139.30 ▲2.9%

02 June 2023, 04:01:00 PM
Volume: 35,196

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.apollohospitals.com
Market Cap 71,422.15 Cr.
Enterprise Value(EV) 73,356.63 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 56.97 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 87.03 Trailing Twelve Months Ending 2023-03
Industry PE 48.54 Trailing Twelve Months Ending 2023-03
Book Value / Share 430.46 Trailing Twelve Months Ending 2023-03
Price to Book Value 11.52 Calculated using Price: 4,957.90
Dividend Yield 0.30 Period Ending 2022-03
No. of Shares Subscribed 14.38 Cr. 143,784,657 Shares
FaceValue 5
About Apollo Hospitals Enterprise Ltd.
The company has emerged as Asia's foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics and several retail health models. The Group also has Telemedicine facilities across several countries, Health Insurance Services, Global Projects Consultancy, Medical Colleges, Medvarsity for E-Learning, Colleges of Nursing and Hospital Management and a Research Foundation. In addition, ‘ASK Apollo' - an online consultation portal and Apollo Home Health provide the care continuum.

Apollo Hospitals Enterprise Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Apollo Hospitals Enterprise Ltd. Performance

View details >>
1 Day
+2.89%
1 Week
+7.54%
1 Month
+10.61%
3 Month
+12.60%
6 Month
+1.77%
1 Year
+36.01%
2 Year
+51.48%
5 Year
+434.20%
10 Year
+394.09%

Apollo Hospitals Enterprise Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 10.66 10.59 7.25 3.96 1.82 6.07 13.08 3.44 21.60
Return on Capital Employed (%) 12.71 12.09 9.05 7.62 7.12 10.24 17.13 9.32 24.92
Return on Assets (%) 6.00 5.51 3.40 1.62 0.66 2.05 3.90 1.10 8.18

Apollo Hospitals Enterprise Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 2,977 3,171 3,331 3,313 3,252 3,334 3,339 4,603 5,623 6,197
Non Curr. Liab. 1,557 2,138 2,701 4,399 4,423 4,613 6,483 5,590 6,241 4,560
Curr. Liab. 797 1,076 1,250 963 1,567 1,955 2,337 2,038 2,383 3,325
Minority Int. 19 73 78 125 132 136 131 200 254 334
Equity & Liab. 5,350 6,459 7,360 8,800 9,374 10,037 12,290 12,431 14,502 14,416
Non Curr. Assets 3,849 4,520 5,385 6,671 7,154 7,756 9,643 8,789 10,381 10,079
Curr. Assets 1,501 1,939 1,975 2,129 2,220 2,282 2,647 3,642 4,122 4,337
Misc. Exp. not W/O
Total Assets 5,350 6,459 7,360 8,800 9,374 10,037 12,290 12,431 14,502 14,416

Apollo Hospitals Enterprise Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 4,384 5,178 6,215 7,256 8,243 9,617 11,247 10,560 14,663 16,612
Other Income 21 37 53 44 34 32 33 49 78 90
Total Income 4,406 5,215 6,267 7,300 8,277 9,650 11,280 10,609 14,741 16,703
Total Expenditure -3,712 -4,444 -5,534 -6,549 -7,452 -8,555 -9,666 -9,427 -12,478 -14,563
PBIDT 694 771 733 751 825 1,095 1,614 1,182 2,263 2,140
Interest -119 -118 -180 -257 -295 -327 -533 -449 -379 -381
Depreciation -168 -212 -264 -314 -359 -396 -620 -573 -601 -615
Taxation -102 -130 -97 -91 -112 -173 -225 -85 -477 -256
Exceptional Items 13 16 198 61 294
PAT 305 325 235 131 60 199 435 136 1,101 888
Minority Interest 1 5 1 90 58 36 23 14 -53 -25
Share Associate 10 9 1 -3 1 7 -43
Other Related Items -11
Consolidated Net Profit 317 340 226 221 117 236 455 150 1,056 819
Adjusted EPS 23 24 16 16 8 17 33 10 73 57

Apollo Hospitals Enterprise Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 443 373 470 597 623 537 905 1,293 1,265 1,628
Cash Fr. Inv. -733 -356 -759 -888 -1,152 -405 -711 -289 -863 -778
Cash Fr. Finan. 373 -63 392 330 477 -109 -215 -910 -340 -793
Net Change 83 -46 103 39 -52 24 -20 95 61 57
Cash & Cash Eqvt 320 274 377 379 283 306 286 381 425 583

Apollo Hospitals Enterprise Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 29.82 29.82 29.82 29.33 29.33 29.33 29.33 29.33 29.33
Public 70.09 70.12 70.12 70.61 70.61 70.67 70.67 70.67 70.67
Depository Receipts 0.09 0.06 0.06 0.06 0.06 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 27.94 29.95 22.08 22.32 16.37 16.37 16.37 16.37 16.63

Apollo Hospitals Enterprise Ltd. Announcements

View details >>
Fri, 02 Jun 2023
Announcement under Regulation 30 (LODR)-Meeting Updates
as per annexure enclosed
Fri, 02 Jun 2023
Intimation Regarding The Change In Date Of The 42Nd Annual General Meeting (AGM)
as per annexure enclosed
Wed, 31 May 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir Sub: Intimation in terms of Regulation 39(3) of the SEBI (LODR) Regulations 2015 (Regulations) regarding loss of share certificate.This is to inform you that the Company has received intimation from shareholders on May 30 2023 regarding loss of share certificates. In accordance with Regulation 39(3) of the Regulations the details of the said share certificates are as given below:Folio No. Name of the Shareholder(s) No of equity shares held Share Certificate No. Distinctive Nos.4453 Malini ShunmugamC R Shunmugam 100 354454 5707641 to 57077408706 C R ShunmugamC T Radhakrishnan 20 358709 7547195 to 7547214This is for your information.

Apollo Hospitals Enterprise Ltd. Technical Scans

View details >>
Fri, 02 Jun 2023
Close Crossing 52 Week High Close Crossing 52 Week High
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Week High Close Above Last Week High
Close Above Last Month High Close Above Last Month High

Apollo Hospitals Enterprise Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 239,777.54 999.35 +1.2%
Divi's Laboratories Ltd. 93,340.08 3,539.90 +0.4%
Cipla Ltd. 77,917.34 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. 76,753.53 4,610.45 +1.3%
Torrent Pharmaceuticals Ltd. 60,134.99 1,774.00 -0.1%
Mankind Pharma Ltd. 58,728.27 1,466.05 +4.9%
Zydus Lifesciences Ltd. 52,487.85 519.40 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 28.30 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 51.54 3,539.90 +0.4%
Cipla Ltd. Consolidated 2023-03 27.85 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.03 4,610.45 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.23 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 43.99 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 26.82 519.40 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.28 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7.36 3,539.90 +0.4%
Cipla Ltd. Consolidated 2023-03 3.33 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.30 4,610.45 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.69 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 5.65 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 3.00 519.40 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 0.04 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,610.45 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 519.40 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 13.10 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,610.45 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 519.40 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 13.10 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,610.45 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 519.40 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 21,763.34 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,610.45 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 519.40 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 2,559.47 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,610.45 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 519.40 +1.2%

Apollo Hospitals Enterprise Ltd. FAQ's

What is Apollo Hospital Ent. share price?
Can I buy Apollo Hospital Ent. shares now?
What is the Dividend Yield of Apollo Hospital Ent.?
What is the Market Cap of Apollo Hospital Ent.?
What are the key metrics to analyse Apollo Hospital Ent.?
What is the 52 Week High and Low of Apollo Hospital Ent.?
What is the trend of Apollo Hospital Ent. share price?